Edition:
India

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

3.00EUR
14 Nov 2018
Change (% chg)

€-0.03 (-0.83%)
Prev Close
€3.03
Open
€2.98
Day's High
€3.02
Day's Low
€2.96
Volume
44,550
Avg. Vol
52,040
52-wk High
€3.46
52-wk Low
€2.40

Chart for

About

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for... (more)

Overall

Beta: -0.15
Market Cap(Mil.): €186.79
Shares Outstanding(Mil.): 56.43
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates